The Ideal Platform for
Australian researchers are pioneering work in health and personalised medicine.
biomedical engineer,
University of New South Wales
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam mauris ante, bibendum in dui id, convallis hendrerit sem. Proin massa augue, ultrices non vulputate id, auctor eu ex. Nullam at purus ante. Interdum et malesuada fames ac ante ipsum primis in faucibus. Pellentesque pretium nisi nec erat posuere, in sollicitudin nisl mattis. Donec quis lacus in nulla ultricies venenatis vel in tellus. Donec in dictum lectus, vel pretium sapien. Aenean a scelerisque nisi. Ut vehicula lectus nec est accumsan interdum. In ut vestibulum enim. Nullam feugiat scelerisque massa id gravida.
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam mauris ante, bibendum in dui id, convallis hendrerit sem. Proin massa augue, ultrices non vulputate id, auctor eu ex. Nullam at purus ante. Interdum et malesuada fames ac ante ipsum primis in faucibus. Pellentesque pretium nisi nec erat posuere, in sollicitudin nisl mattis. Donec quis lacus in nulla ultricies venenatis vel in tellus. Donec in dictum lectus, vel pretium sapien. Aenean a scelerisque nisi. Ut vehicula lectus nec est accumsan interdum. In ut vestibulum enim. Nullam feugiat scelerisque massa id gravida.
We can help
Whether you’re running a top-tier business or you’re an exceptional leader in your field, we're here to smooth the way.
distributed annually to support innovation
6
Accounted
We know our landscapes and lifestyle are very attractive, but we also know there’s much more.
DISCOVER MORE
DISCOVER MORE
Get Started
Get Started
export sector
8.
billion
and growing
1,
companies
Australian research has yielded remarkable discoveries. Among them are Penicillin-based antibiotics, ultrasounds, in-vitro fertilisation, the bionic ear and a vaccine for cervical cancer.
“Australia is driving outstanding and cutting edge research and discoveries in the fields of biomedical engineering and medical technology,” said Dr Fatemeh Karimi, Vice Chancellor’s Research Fellow at the University of New South Wales Graduate School of Biomedical Engineering.
“For example, 3D printing of artificial organs or tissue, like artificial hearts and artificial skin, as well as developing novel medical technologies to improve health outcomes. And all this opens a great opportunity for collaboration.”
Today, Australia ranks eighth globally for life sciences research. Its world-leading researchers have won seven Nobel Prizes for their extraordinary contributions to physiology and medicine. The same quest for excellence continues to advance oncology, neurology, regenerative medicine, nanotechnology, 3D medical printing and more.
“Australia has a highly skilled, diverse and collaborative healthcare workforce,” said Mark Nevin, CEO of the Royal Australia & New Zealand College of Radiologists.
“It offers world-class medical research infrastructure built on strong medical institutions, a thriving not-for-profit sector and ongoing government investment. That has attracted many world-leading health and life science researchers.”
Drawn by an extensive network of top-ranked universities, medical precincts, industry accelerators and home-grown talent, global innovators flock to Australia for the opportunity to collaborate on healthcare solutions.
“Australia’s competitiveness lies in its openness,” says Dr. Xiaonan Zhang, an Associate Professor leading research in the treatment of hepatitis B at University of Canberra.
“Australia’s dynamic society and liberal universities make it a very attractive destination for brilliant thinkers from around the world. If you look at our research labs, a high percentage of newer generation scientists are immigrants or foreign students. This brings in new ways
of thinking, which is a huge advantage for Australia.”
Australia is spending billions of dollars in grants and incentives to drive innovation in the sector.
“The Australian government has a long history of providing generous grants for universities and industry,” said Dr Karimi.
“This helps universities and companies to stay competitive, improve productivity and stimulate the national economy.”
One of the largest endowment funds of its kind globally, the Australian Government's A$20 billion (US$14.7 billion) Medical Research Future Fund (MRFF) disburses more than A$600 million (US$442 million) annually to support exciting medical research and innovation.
Among them:
The Australian Government also finances half of the A$500 million (US$368 million) Biomedical Translation Fund (BTF). The BTF provides companies with venture capital through private sector fund managers.
Dr Karimi added, “Australia's world-class health sector remains ready to support major opportunities for future growth and investment.”
Financial Inter-Connectivity
Financial Services
& FinTech
How Hong Kong’s Financial Centre Leadership Can Power the GBA
A$
%
#754ab6
A Medtech Powerhouse
Advantages
Open for
Business
FinTech
explore
Financial Services &
Financial Services
& FinTech
FinTech
How Hong Kong’s Financial Centre Leadership Can Power the GBA
agriculture
food &
Health &
Life Science
Minerals
Energy
Renewable
FinTech
you
DISCOVER MORE
Critical
Australia’s world-class medical innovations are saving and enhancing lives.
Mark Nevin,
Research
At A$8.2 billion (US$6.1 billion), health and life sciences is Australia’s eight-largest export sector. Industry players export to the world’s biggest markets including the U.S., U.K., China and Germany.
Australia’s advanced manufacturing capabilities enable companies to scale.
Medtech is one of Australia’s manufacturing priorities for the next decade that will strengthen local supply chains and enhance the delivery of high-value dynamic products.
Australia’s national science agency, CSIRO, continues to unlock massive potential by forging global supply chains. Renowned for its work on world-firsts, CSIRO has collaborated with industry partners on printing human body parts, including an artery stent, a sternum and a heel.
Massive Export
Opportunities
CEO of the Royal Australian & New Zealand College of Radiologists
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Financial Services &
FinTech
Financial Services
& FinTech
FinTech
How Hong Kong’s Financial Centre Leadership Can Power the GBA
agriculture
food &
Health &
Life Science
Minerals
Critical
Energy
Renewable
Director, Peter Doherty Institute for Infection and Immunity
01
Research
Massive Export
02
Open for
03
Delight in Unforgettable Panoramic Views
04
Stay Contact-Free on the Go
05
Advantages
Opportunities
Business
01
02
03
01
Ideal Platform for
FINTECH
02
Food &
FIBER
03
CRITICAL
MINERALS
05
Renewable
ENERGY
Australia –
R
R
R
R
Interview with
Sharon Lewin
2
8
0
0
+
DISCOVER MORE
DISCOVER MORE
Australia accelerates
your business.
DISCOVER MORE
DISCOVER MORE
Australia accelerates
your business.
1
More than 1,200 medtech, biotech and pharmaceutical companies enrich Australia’s vibrant health and life sciences ecosystem.
Among them are global powerhouses like Cochlear and Telix Pharmaceuticals, while young companies like Synchron, Vaxxas and Global Kinetics Corporation power the next wave of exciting innovators.
Australia is the ideal test bed for new technologies and medicines. Rapid approvals and high-quality institutions accelerate the development cycle for therapies and devices.
Clinical trials are also cost-efficient, being 28% cheaper than in the U.S. When tax incentives are taken into account, Australian clinical trials cost nearly 60% less than they do in the U.S.
Accessibility is another Australian advantage, with 50 clinical trial networks and as many biobanks. And start-ups like HealthMatch connect patients with researchers who are trialling revolutionary treatments.
“There is a far simpler regulatory environment for clinical trials in Australia allowing for more rapid implementation of phase 1 and 2 studies,” said Professor Sharon Lewin, Director of the Peter Doherty Institute for Infection and Immunity.
“We also have outstanding clinical trial facilities. The majority of our public hospitals have electronic medical records allowing suitable participants to be easily identified.”
2
3
4
Nature Index
Australian Academy of Science
Frost & Sullivan
MTPConnect
Department of Industry, Science, Energy and Resources
CSIRO, CSIRO, CSIRO
AU Govt
AU Govt
1
2
3
4
5
6
7
8
Market capital $US 2.6 billion July 2021
Dr. Fatemeh Karimi,
Billions in
Support & Funding
Director of the Peter Doherty Institute for Infection and Immunity
Sharon Lewin,
Australia also have outstanding clinical trial facilities for both phase 1 and 2 trials. The majority of our public hospitals has electronic medical records allowing for easy identification of suitable participants.
2
Billions in
Support & Funding
02
1
Over A$
Australia offers world-class medical research infrastructure built on strong medical institutions, a thriving not-for-profit sector and ongoing government investment.
(COMING SOON)
(COMING SOON)
million
0
6
7
The Frontier Health and Medical Research Initiative supports Australia’s best researchers to pursue big ideas that can revolutionise healthcare and potentially create new industries.
The Medical Research Commercialisation Initiative supports early-stage medical research and innovation through to proof-of-concept and commercialisation.
Research Missions support the exploration of new treatments for national health priorities, including cancer, mental health and rare diseases.
8
0
5
01
A Hub for
Agrifood Innovation
Open for
Business
03
Delight in Unforgettable Panoramic Views
04
Stay Contact-Free on the Go
05
Research
Advantages
Massive Export
Opportunities
Australia’s world-class medical innovations are saving and enhancing lives.
biomedical engineer,
University of New South Wales
Australian researchers are pioneering work in health and personalised medicine.
Mark Nevin,
CEO of the Royal AustraliaN & New Zealand College of Radiologists
2
3
Market capital $US 2.6 billion July 2021
Director, Peter Doherty Institute for Infection and Immunity
Sharon Lewin
Interview with
8.
2
export sector
billion
A$
1,
0
0
+
and growing
companies
6
distributed annually to support innovation
Accounted
Nature Index
Australian Academy of Science
Frost & Sullivan
MTPConnect
Department of Industry, Science, Energy and Resources
CSIRO, CSIRO, CSIRO
AU Govt
AU Govt
1
2
3
4
5
6
7
8
Australia is spending billions of dollars in grants and incentives to drive innovation in the sector.
“The Australian government has a long history of providing generous grants for universities and industry,” said Dr Karimi.
“This helps universities and companies to stay competitive, improve productivity and stimulate the national economy.”
One of the largest endowment funds of its kind globally, the Australian Government's A$20 billion (US$14.7 billion) Medical Research Future Fund (MRFF) disburses more than A$600 million (US$442 million) annually to support exciting medical research and innovation.
The Australian Government also finances half of the A$500 million (US$368 million) Biomedical Translation Fund (BTF). The BTF provides companies with venture capital through private sector fund managers.
Dr Karimi added, “Australia's world-class health sector remains ready to support major opportunities for future growth and investment.”
05
Renewable
ENERGY
02
Food &
FIBER
03
CRITICAL
MINERALS
01
Ideal Platform for
FINTECH
R